Your Location:Home >Products >API >936563-96-1

Purity:99%
Export Top Purity Ibrutinib 936563-96-1 In Stock We supply high quality Ibrutinib (CAS 936563-96-1), in stock, factory directly supply to clients, lower prices, more competitiveness.
Ibrutinib is , while it's Molecular Formula is C25H24N6O2. Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.
The CAS number of Ibrutinib is 936563-96-1.
More information of Ibrutinib 936563-96-1 are:
|
Synonyms |
PCI-32765;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one; |
|
CAS Number |
936563-96-1 |
|
Molecular Formula |
C25H24N6O2 |
|
Molecular Weight |
440.505 |
|
Density |
1.3±0.1 g/cm3 |
|
Boiling Point |
715.0±60.0 °C at 760 mmHg |
|
Flash Point |
386.2±32.9 °C |
|
PSA |
99.16000 |
|
LogP |
4.73640 |
|
Pka |
4.09±0.30(Predicted) |
In November 2013, the US FDA approved ibrutinib (also referred to as PCI-32765), for the treatment of patients with mantle cell lymphoma (MCL) who had received at least one prior therapy. Ibrutinib is the second oral agent approved for the treatment of MCL. It works by irreversibly inhibiting Bruton’s tyrosine kinase (Btk) leading to the inhibition of B-cell receptor signaling and resulting in the reduction of malignant B-cell proliferation and induction of cell death. Btk plays an important role in the differentiation, development, proliferation, and survival of B cells via activation of cell-cycle regulators and regulating the expression of pro- and antiapoptotic proteins. Aberrant Btk activity results in a variety of B-cell malignancies including MCL. Ibrutinib inhibits Btk by irreversibly binding to cysteine-481 in the active site thereby inhibiting phosphorylation of tyrosine-223 and affecting downstream B-cell signaling pathways. Ibrutinib is a potent inhibitor of Btk (IC50=0.5 nM) and is efficacious in canine models of B-cell lymphoma. At dose ranges of 2.5–20 mg/kg, there was full occupancy of Btk in peripheral blood and tumor tissue for 24 h. A synthetic route to ibrutinib that employs Suzuki coupling of 3-iodo-1Hpyrazolo[3,4-d]pyrimidin-4-amine with (4-phenoxyphenyl)boronic acid followed by Mitsunobu reaction with N-Boc-3-hydroxypiperidine as key steps has been reported.
Articles related to Ibrutinib:
|
Article |
Source |
|
A synthetic method of ibutinib |
- , (2022/03/02) |
|
Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry |
Reddi, Rambabu N.,Resnick, Efrat,Rogel, Adi,Rao, Boddu Venkateswara,Gabizon, Ronen,Goldenberg, Kim,Gurwicz, Neta,Zaidman, Daniel,Plotnikov, Alexander,Barr, Haim,Shulman, Ziv,London, Nir supporting information, p. 4979 - 4992 (2021/05/04) |
Zibo Yurui Biotechnology Co., Ltd is a quality supplier and manufacturer of Ibrutinib . You can buy high quality, low price Ibrutinib 936563-96-1 here. Contact us.
CAS:195875-84-4
CAS:2023788-19-2
CAS:136572-09-3
CAS:906093-29-6